Eckert & Ziegler Strahlen- und Medizintechnik AG
A global provider of isotope technology for medical, scientific, and industrial use.
EUZ | F
Overview
Corporate Details
- ISIN(s):
- DE0005659700
- LEI:
- 391200EUDABLUKXCKG48
- Country:
- Germany
- Address:
- Robert-Rössle-Str. 10, 13125 Berlin
- Website:
- https://www.ezag.com/startseite/
- Sector:
- Manufacturing
Description
Eckert & Ziegler Strahlen- und Medizintechnik AG is a global provider of isotope technology for medical, scientific, and industrial use. The company's core business focuses on cancer therapy, industrial radiometry, and nuclear-medical imaging. It specializes in developing and manufacturing radioactive components and related equipment. Key offerings for the medical sector include products and services for nuclear medicine and radiation therapy, such as radiopharmaceuticals, radiosynthesis and quality control (QC) solutions, and sealed radiation sources. The company also provides essential infrastructure like hot cells and radiation protection solutions, supporting the radiopharmaceutical industry from early development through to commercial production.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-12-08 09:07 | English | 16.0 KB | |||
| 2022-12-06 11:27 |
Eckert & Ziegler Strahlen- und Medizintechnik AG: Prof. Dr. Wolfgang Maennig, b…
|
English | 7.8 KB | ||
| 2022-11-25 15:36 |
Eckert & Ziegler Receives Green Light for Phase III Study with PENTIXAFOR
|
English | 6.3 KB | ||
| 2022-11-21 13:33 | English | 14.5 KB | |||
| 2022-11-10 00:00 |
Q3 statement / Q3 financial report 2022
|
English | 765.9 KB | ||
| 2022-11-08 07:45 |
Eckert & Ziegler: Nine-Month Figures Show Strong Sales Growth
|
English | 8.0 KB | ||
| 2022-10-27 10:59 |
First CNS Lymphoma Patient Imaged with PentixaFor in Phase 2 Trial
|
English | 8.9 KB | ||
| 2022-10-13 13:00 |
Eckert & Ziegler and Alpha-9 Sign Actinium-225 (Ac-225) Reservation Agreement
|
English | 11.9 KB | ||
| 2022-10-11 14:30 |
Eckert & Ziegler to Build Production Line for NorthStar Medical Radioisotopes D…
|
English | 10.6 KB | ||
| 2022-10-05 10:30 | English | 4.0 KB | |||
| 2022-08-11 07:45 |
Eckert & Ziegler with Successful First Half of 2022
|
English | 7.9 KB | ||
| 2022-08-11 00:00 |
Half-yearly financial report 2022
|
English | 860.6 KB | ||
| 2022-08-04 10:07 |
Eckert & Ziegler Affiliate to Receive Multi-Million Euro Grant from the Europea…
|
English | 8.9 KB | ||
| 2022-07-27 12:53 |
Eckert & Ziegler: Strong Growth in Revenues and Earnings in 2nd Quarter
|
English | 6.3 KB | ||
| 2022-07-21 09:00 |
Eckert & Ziegler Affiliate Receives Further NIAID Funding for Clinical Developm…
|
English | 8.6 KB |
Automate Your Workflow. Get a real-time feed of all Eckert & Ziegler Strahlen- und Medizintechnik AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Eckert & Ziegler Strahlen- und Medizintechnik AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Eckert & Ziegler Strahlen- und Medizintechnik AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-08-30 | Eckert, Dr. Andreas | Supervisory board | Sell | None | 1,526,400.00 EUR |
| 2023-08-30 | Eckert Wagniskapital und Frühphasenfinanzierung GmbH | Close relation | Buy | None | 1,526,400.00 EUR |
| 2023-08-11 | Perschmann, Frank | Supervisory board | Buy | None | 16,600.00 EUR |
| 2023-01-13 | NEON Equity AG | Close relation | Buy | None | 2,115.00 EUR |
| 2023-01-12 | Blunck, Dr. Thomas | Board | Sell | None | 57,402.00 EUR |
| 2023-01-12 | Blunck, Dr. Thomas | Board | Sell | None | 32,160.00 EUR |
| 2023-01-11 | Bouterfa, Dr. Hakim | Board | Buy | None | 124,800.00 EUR |
| 2022-12-21 | Eckert Wagniskapital und Frühphasenfinanzierung GmbH | Close relation | Buy | None | 1,432,800.00 EUR |
| 2022-12-06 | Maennig, Prof. Dr. Wolfgang | Supervisory board | Buy | None | 72,745.31 EUR |
| 2022-12-05 | Carpio GmbH | Close relation | Buy | None | 73,826.53 EUR |
Peer Companies
